Brkić S, Aleksić-Dordević M, Belić A, Jovanović J, Bogdanović M
Klinika za infektivne i kozno-venericne bolesti, Medicinski fakultet, Novi Sad.
Med Pregl. 1998 Jul-Aug;51(7-8):355-8.
Acute infections mononucleosis is the most common clinical manifestation of primary Epstein-Barr virus (EBV) infection occurring during adolescence. It is a benign lymphoproliferative, usually self-limiting disease. Complications are relatively rare, but they may occur, especially hematological. Most common are autoimmune hematolytic anemia and thrombocytopenia, and they respond to corticoid therapy. Deuteration of white blood cells is rather rare, whereas mild neutropenia is a normal finding during the course of acute disease. On the other hand, agranulocytosis is extremely rate, and almost every case has been reported in the literature. Filgrastim--the recombinant human granulocyte colony-stimulating factor (G-CSF) stimulates the activation, proliferation and maturation of progenitor granulocyte cells. This drug is usually applied in treatment of iatrogenic neutropenia, during chemotherapy of malignancies and in some idiopathic and cyclic neutopenias.
A female patient, 18 years of age, has been hospitalized at the Clinic of Infectious Diseases in Novi Sad on two occasions. First because of severe acute infectious mononucleosis with acute hepatitis and jaundice 10 days after onset of symptoms. Physical examination revealed severe intoxication, dehydration, icteric skin, mucosis and massive hepatosplenomegaly. The diagnosis was confirmed by ELISA IgM, EBV VCA positive and ELISA IgG EBV VCA and IgG EBVNA negative results. The patient was discharged from hospital after 24 days without complaints and with normal physical and laboratory findings. For several days she felt well, but gradually severe fatigue and malaise occurred and she became febrile again. That was the reason why she was hospitalized again, two weeks later. This time she was febrile, extremely intoxicated with general lymphadenopathy, catarrhal gingivostomatitis and massive splenomegaly. The first laboratory findings showed severe neutropenia (absolute count of granulocytes was 0.156 x 10/l, with only 12% segmented neutrophils). Mild anemia--3.05 x 10/l was also registered, while the platelet count was normal. Other biochemical analyses were normal, the Coombs' test negative, while the serological response was also normal. Bone marrow puncture was performed and normocellular bone marrow was registered, somewhere hypercellular due to hyperplasia of granulocyte progenitor cells from promyelocytes to normal maturated cells. Anemia showed megaloblastoid proliferation, while megakaryocytes were normal. High doses of corticosteroids were applied (dexamethasone 160 mg daily) and filgrastim 5 micrograms every other day. From the very beginning of therapy the patient felt better, whereas granulocytes responded with elevation as soon as 48 hours after initiation of therapy. On the sixth day the treatment was stopped because the level of granulocytes was normal and the patient has completely recovered. She was discharged from hospital 4 weeks later with mild meteorism, but normal physical and laboratory findings and mild splenomegaly registered only by ultrasonography.
During the last 10 years only several cases of severe leukopenia with acute infectious mononucleosis had been reported in literature. In all cases it was associated with some other hematological complications and it occurred in young adults without previously registered immunodeficiency. We have no knowledge about application of filgrastim in treatment of EBV-induced agranulocytosis, but the International Association for Studying Agranulocytosis and Aplastic Anemia reported that in 4% of patients Epstein-Barr virus can cause agranulocytosis even a year after the occurrence of acute disease.
急性感染性单核细胞增多症是青春期原发性爱泼斯坦-巴尔病毒(EBV)感染最常见的临床表现。它是一种良性淋巴细胞增生性疾病,通常为自限性。并发症相对少见,但仍可能发生,尤其是血液系统并发症。最常见的是自身免疫性溶血性贫血和血小板减少症,它们对皮质类固醇治疗有反应。白细胞氘化相当罕见,而轻度中性粒细胞减少是急性疾病过程中的正常表现。另一方面,粒细胞缺乏症极为罕见,文献中几乎每例都有报道。非格司亭——重组人粒细胞集落刺激因子(G-CSF)可刺激祖粒细胞的激活、增殖和成熟。该药物通常用于治疗医源性中性粒细胞减少症、恶性肿瘤化疗期间以及某些特发性和周期性中性粒细胞减少症。
一名18岁女性患者曾两次入住诺维萨德传染病诊所。第一次是因为出现症状10天后,因严重急性感染性单核细胞增多症伴急性肝炎和黄疸入院。体格检查发现严重中毒、脱水、皮肤黄疸、黏膜病变和大量肝脾肿大。ELISA IgM检测EBV VCA呈阳性,ELISA IgG EBV VCA和IgG EBVNA呈阴性,确诊。患者24天后出院,无不适,身体和实验室检查结果正常。几天后她感觉良好,但逐渐出现严重疲劳和不适,再次发热。这就是她两周后再次住院的原因。此次她发热,极度中毒,伴有全身淋巴结病、卡他性龈口炎和大量脾肿大。首次实验室检查显示严重中性粒细胞减少(粒细胞绝对计数为0.156×10⁹/L,仅12%为分叶核中性粒细胞)。还记录到轻度贫血——3.05×10¹²/L,而血小板计数正常。其他生化分析正常,库姆斯试验阴性,血清学反应也正常。进行了骨髓穿刺,记录到骨髓细胞正常,由于从早幼粒细胞到正常成熟细胞的粒细胞祖细胞增生,有些部位细胞增多。贫血表现为巨幼样增生,而巨核细胞正常。应用了高剂量皮质类固醇(地塞米松每日160毫克)和非格司亭隔日5微克。从治疗一开始患者感觉好转,粒细胞在治疗开始后48小时就开始升高。第六天停止治疗,因为粒细胞水平正常,患者已完全康复。4周后她出院,有轻度胃肠胀气,但身体和实验室检查结果正常,仅超声检查发现轻度脾肿大。
在过去10年中,文献中仅报道了几例伴有急性感染性单核细胞增多症的严重白细胞减少症病例。所有病例均伴有其他一些血液系统并发症,且发生在既往无免疫缺陷记录的年轻人中。我们不了解非格司亭在治疗EBV诱导的粒细胞缺乏症中的应用,但国际粒细胞缺乏症和再生障碍性贫血研究协会报告称,4%的患者即使在急性疾病发生一年后,爱泼斯坦-巴尔病毒也可导致粒细胞缺乏症。